Precipio (PRPO) Stock Price

Precipio Price

NASDAQ·CLOSED
22.45
​
Market closed

Over the last 19 years Precipio grew revenue by 0.1% annually, reaching 24.05 M USD. For Precipio, the net margin of -1.5% is up versus -96.6% a few years ago. The consensus 12-month price target for Precipio is 19.38 USD, about 13.7% below where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Precipio stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Precipio business model & stock analysis

Precipio, Inc. generates revenue through its cancer diagnostics platform, which includes IV-Cell, HemeScreen, and ICE-COLD-PCR (ICP) technologies. The company develops and sells these proprietary diagnostic tools to physicians and healthcare providers who seek to improve diagnostic accuracy and reduce misdiagnosis rates. IV-Cell addresses selective culturing issues with a universal media for hematopoietic cell lineages, while ICP enhances molecular test sensitivity through specimen enrichment. HemeScreen offers a rapid gene screening panel for efficient diagnostics. The firm targets healthcare institutions and medical professionals who require advanced diagnostic solutions for cancer detection. Physicians and their patients benefit from the platform's ability to provide necessary technology for accurate diagnoses. Precipio focuses on developing and commercializing these technologies to address the critical need for reliable cancer diagnostics in clinical practice. Precipio's products are designed to eliminate misdiagnosis problems in cancer diagnostics, with IV-Cell, HemeScreen, and ICP serving as key components of its revenue-generating portfolio. The company's platform enables access to essential diagnostic tools, supporting healthcare providers in delivering precise cancer diagnoses and improving patient outcomes.

Frequently asked questions about Precipio

Analysts currently set an average price target of 19.38 USD for the Precipio stock (median: 19.38 USD), implying -13.7 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Precipio stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Precipio to generate revenue of 80.26 M USD and earnings per share of 29.87 USD.

Converted at the current exchange rate, the Precipio share trades at 20.00 EUR (22.45 USD).

The Precipio share (PRPO) is listed on 5 stock exchanges, including: NASDAQ (PRPO), SIX (Zürich) (TGKQ.SW), Frankfurt (TGKQ.F), München (TGKQ.MU), Düsseldorf (TGKQ.DU).

The expected revenue of Precipio is 80.26 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Precipio is 47.95 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Precipio is currently 0.75. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Precipio stock.

The price-to-sales ratio (P/S) of Precipio is currently 0.45. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Precipio stock.

The Eulerpool Quality Score for Precipio is 4/10.

The ISIN of Precipio is US74019L6020. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Precipio is A2PH8V. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Precipio is PRPO. The ticker symbol is used to trade Precipio shares on the stock exchange.

Fair ValueTerminal
20.21 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
394,245.90 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jul 18, 2000
ISIN
US74019L6020
Cusip
74019L503
Sedol
BJRFDD4
Market capitalization
39.30 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
0.82
P/S
P/Se
0.45
EV/EBIT
—
P/B Ratio
2.70
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.99 %
Last updated Oct 21, 2026, 8:33 PM

Precipio Ticker

DÜSSELDORF · TGKQ.DUFRANKFURT · TGKQ.FMUNICH · TGKQ.MUNASDAQ · PRPOSIX · TGKQ.SW

All fundamentals and in-depth analysis of Precipio

Our stock analysis for Precipio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Precipio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.